Proportion of individuals that change US findings from D0 to D21 and D0 to M3.

Table 2: Proportion of individuals that change US findings from D0 to D21 and D0 to M3.

Right Synovitis		Baseline to end of treatment			Baseline to follow-up
		No	Mild	Moderate	No	Mild	Moderate
		n (%)	n (%)	n (%)	n (%)	n (%)	n (%)
Thermal Group	No	10 (90.9)	1 (9.1)	-	3 (27.3)	6 (54.5)	2 (18.2)
	Mild	5 (83.3)	1 (16.7)	-	2 (33.3)	2 (33.3)	2 (33.3)
	Moderate	-	2 (66.7)	1 (33.3)	-	3 (100.0)
	p-value			0.097			0.241
Control Group	No	4 (100.0)	-	-	4	-	-
	Mild	7 (63.6)	4 (36.4)	-	8 (72.7)	2 (18.2)	1 (9.1)
	Moderate	-	2 (40.0)	3 (60.0)	1 (20.0)	2 (40.0)	2 (40.0)
	p-value			0.011			0.025
Left Synovitis
Thermal Group	No	4 (100.0)	-	-	4	-	-
	Mild	6 (60.0)	3 (30.0)	1 (10.0)	6 (60.0)	2 (20.0)	2 (20.0)
	Moderate	3 (50.0)	2 (33.3)	1 (16.7)	2 (33.3)	1 (16.7)	3 (50.0)
	p-value			0.025			0.040
Control Group	No	10 (100.0)	-	-	9 (90.0)	1 (10.0)	-
	Mild	3 (37.5)	5 (62.5)	-	4 (50.0)	3 (37.5)	1 (12.5)
	Moderate	-	-	1 (100.0)	-	-	1 (100.0)
	p-value			0.083			0.247